ARTICLE | Company News
Medarex, GenPat77 autoimmune deal
August 23, 2006 12:48 AM UTC
MEDX will use its UltiMab Human Antibody Development System to generate antibodies against autoimmune disease targets from GenPat77 (Berlin, Germany). The companies will share product development and ...